2023 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãß°èÇмú´ëȸ : 2023-12-02
±³À°ÀÏÀÚ : 2023-12-02
±³À°Àå¼Ò : ¼¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ & ´ëȸÀǽÇ
±³À°ÁÖÁ¦ : 2023 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ
´ã´çÀÚ : ±è¹Ì¼Û
¿¬¶ôó : 02-0000-0000
À̸ÞÀÏ : mskim@ls-comm.co.kr
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í "»çÀüµî·Ï Á¤È¸¿ø(Àü¹®ÀÇ)(3¸¸¿ø) / ÁØȸ¿ø(Àü°øÀÇ)(2¸¸¿ø) / ÀϹÝȸ¿ø(°£È£»ç, ±â»ç µî)(2¸¸¿ø) / ºñȸ¿ø(4¸¸¿ø)
ÇöÀåµî·Ï Á¤È¸¿ø(Àü¹®ÀÇ)(4¸¸¿ø) / ÁØȸ¿ø(Àü°øÀÇ)(3¸¸¿ø) / ÀϹÝȸ¿ø(°£È£»ç, ±â»ç µî)(3¸¸¿ø) / ºñȸ¿ø(5¸¸¿ø)"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 09:00~09:20 I. Fundamental concepts: Brain-lung interaction ¹ÚÁø(À̴뼿ﺴ¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 09:20~09:40 II. Neurological diseases: Traumatic brain injury À¯Á¤¾Ï(»ï¼º¼¿ïº´¿ø )
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 09:40~10:00 III. Systemic diseases: Endocrine disorders È«¾Æ¶÷(ȼøÀü³²´ëº´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 10:00~10:20 IV. Monitoring and procedures: Airway managements Á¤ÁøÇå(µ¿¾Æ´ëÇб³º´¿ø )
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 10:20~10:40 V. Prognostication and end-of-life care: Neuroprognostication À̼ºÁØ(¾ÆÁÖ´ëÇб³º´¿ø)
Åä·Ð 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 10:40~10:50 Discussion ()
ÈÞ½Ä 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 10:50~11:00 Coffee Break ()
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 11:00~11:20 Diagnostic modalities to assess covert consciousness in neuro-ICU ÀÌÇöÁ¶(¿ï»ê´ëÇб³º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 11:20~11:40 AI prediction using large language models in neuro-ICU Á¤Çѱæ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
Åä·Ð 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 11:40~11:50 Discussion ()
ÈÞ½Ä 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 11:50~12:00 Coffee Break ()
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 12:00~12:30 Argatroban: A new therapeutic modality in acute ischemic stroke À¯ÁØ»ó(¿ëÀμ¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ë¿¬È¸Àå 12:30~13:00 Introduction to latest research in NCC ±èÅÂÁ¤, ±èÄ¡°æ, ÀÌÇѺó, ¼Á¤È, Á¶ÇÑÁø(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø, °í·ÁÀÇ´ë °í·Á´ë±¸·Îº´¿ø, °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø, ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø, ºÎ»êÀÇ´ë ºÎ»ê´ëÇб³º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 14:00~14:20 Large hemispheric infarction: Overview Àü»ó¹ü(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 14:20~14:45 Endovascular reperfusion therapy in large hemispheric infarction: PRO ¿ìÈ£°É(°æÈñ´ëÇб³º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 14:45~15:10 Endovascular reperfusion therapy in large hemispheric infarction: CON ±èÁß±¸(Á¦ÁÖ´ëÇб³º´¿ø)
ÈÞ½Ä 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 15:10~15:20 Coffee Break ()
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 15:20~15:40 Unveiling the link: Hyponatremia and respiratory failure in ALS ¼º¿øÀç(ÇѾç´ëÇб³º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 15:40~16:00 Acute neurological symptoms after procedures: r/o cerebral air embolism ±è¿µ¼(¿ø±¤´ëÇб³º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 16:00~16:20 Early neurological deterioration in acute ischemic stroke ±èÇö¼ö(Àü³²´ëÇб³º´¿ø)
Åä·Ð 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ1 16:20~16:30 Discussion ()
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ2 14:00~14:35 Airway assessment and management ¹ÚÁöÀº(°æÈñ´ëÇб³º´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ2 14:35~15:10 Breathing support and neurological respiratory assessment ±èÅÂÀ±(°í´ë¾È¾Ïº´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ2 15:10~15:45 Circulatory management and hemodynamic monitoring ÀüÁöÀº(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 12¿ù 02ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ2 15:45~16:20 Disability assessment and neurological monitoring À¯ ¿µ(ÀºÆò¼º¸ðº´¿ø)